7-bromo-6-chlorofebrifugine,
halofuginone,
halofunginone,
Stenorol,
Halofuginone hydrobromide,
64924-67-0,
Stenorol,
Tempostatin,
Halofuginone (hydrobromide),
NSC-713205,
7-Bromo-6-chloro-3-(3-((2S,3R)-3-hydroxypiperidin-2-yl)-2-oxopropyl)quinazolin-4(3H)-one hydrobromide,
Ru 19110,
RU-19110,
7-Bromo-6-chloro-3-(3-((2S,3R)-3-hydroxypiperidin-2-yl)-2-oxopropyl)quinazolin-4(3H)-one hydrobromid,
Halofuginone hydrobromide (USAN),
Stenorol (TN),
NSC713205,
AC1L8G9H,
AC1Q23BC,
SCHEMBL608785,
CHEMBL1969752,
CTK5C1868,
HY-N1584A,
4(3H)-Quinazolinone,7-bromo-6-chloro-3-[3-[(2R,3S)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-,hydrobromide (1:1), rel-,
ANW-44902,
HT-100,
AKOS015920268,
API0016607,
SB19687,
7-bromo-6-chloro-3-{3-[(2s,3r)-3-hydroxypiperidin-2-yl]-2-oxopropyl}quinazolin-4(3h)-one hydrobromide(1:1),
BR-72845,
AX8187929,
TC-133647,
CS-0081860,
FT-0669097,
D04413,
924H670,
Q-201183,
UNII-PTC2969MV1 component SJUWEPZBTXEUMU-LDXVYITESA-N,
Halofuginone hydrobromide, VETRANAL(TM), analytical standard,
4(3H)-Quinazolinone,3S)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-, monohydrobromide, rel-,
7-bromo-6-chloro-3-[3-[(2S,3R)-3-hydroxypiperidin-2-yl]-2-oxopropyl]quinazolin-4-one hydrobromide,
trans-( inverted exclamation markA)-7-Bromo-6-chloro-3-[3-(3-hydroxy-2-piperidinyl)-2-oxopropyl]-4(3H)-quinazolinone monohydrobromide,
Halofunginone,
Halofuginone,
Halofuginonehydrobromide,
UNII-PTC2969MV1,
Halofuginone hydrobromide [USAN],
AR-1H3207,
CID400771,
C16-H17-Br-Cl-N3-O3.Br-H,
Halofuginone HBr ((2R,3S) and (2S,3R) mixture),
(+-)-trans-7-Bromo-6-chloro-3-(3-(3-hydroxy-2-piperidyl)-acetonyl)-4(3H)-quinazolinone monohydrobromide,
(+/-)-trans-7-Bromo-6-chloro-3-(3-(3-hydroxy-2-piperidyl)-acetonyl)-4(3H)-quinazolinone monohydrobromide,
4(3H)-Quinazolinone, 7-bromo-6-chloro-3-(3-(3-hydroxy-2-piperidinyl)-2-oxopropyl)-, hydrobromide, trans-(+/-)-,
65405-66-5,